Analyst Ratings February 2, 2026

Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target

Analyst projects multi-fold earnings growth through 2027 as chiplet adoption and new device wins expand testing demand

By Sofia Navarro TER
Aletheia Capital Starts Coverage on Teradyne With Buy Rating, $400 Target
TER

Aletheia Capital launched coverage of Teradyne (TER) with a Buy rating and a $400 price target, projecting earnings to triple between fiscal years 2025 and 2027. The firm cites accelerating demand for semiconductor test equipment driven by heterogeneous chiplet architectures and a roster of new device opportunities as primary growth levers.

Key Points

  • Aletheia Capital initiated coverage on Teradyne with a Buy rating and a $400 price target.
  • The firm forecasts Teradyne’s earnings to triple between fiscal years 2025 and 2027, driven by testing-market growth, new customer wins, and rising content value.
  • Aletheia sees Teradyne as a primary beneficiary of rapid adoption of heterogeneous chiplet architectures, and highlights multiple device and component opportunities that could increase test content and market size.

Aletheia Capital has begun coverage of Teradyne (NASDAQ:TER), assigning a Buy rating and setting a $400.00 price target. The research note, published Monday, frames the stock as well positioned to benefit from a pronounced expansion in the semiconductor testing market.

The firm expects Teradyne’s earnings to increase roughly threefold between the company’s fiscal years 2025 and 2027. Aletheia attributes that projection to a combination of what it describes as explosive market growth for testing equipment, the capture of new customer engagements, and an uptick in content value per device.

Central to the thesis is Aletheia’s view that Teradyne stands to gain materially from the rapid adoption of heterogeneous chiplet architectures within artificial intelligence and high-performance computing devices. The research note states that such architectural shifts could, in Aletheia’s view, drive the testing market to roughly double in size by the end of the decade.

Specific device and component opportunities cited by the firm include Rubin and Rubin Ultra GPUs, the Vera CPU, CPX, Google’s Axion CPU, and increased test content across networking and system components such as Mellanox’s networking portfolio, Broadcom switches, Apple’s A20 SoC, HBM4E memory, and CPO (co-packaged optics). Aletheia argues these product-level engagements would raise the per-unit revenue opportunity for test equipment providers like Teradyne.

Aletheia Capital added Teradyne to its Alpha Portfolio as part of the initiation. The $400 price target represents a 30x price-to-earnings multiple based on the firm’s fiscal year 2027 earnings estimates.


Alongside the note on Teradyne, the research environment referenced several other technology-sector developments. The firm noted that Google, a division of Alphabet, took legal action against the Chinese company Ipidea, reportedly taking down domains over concerns about unauthorized software installations on millions of devices.

Analyst coverage across large-cap technology names has also been active. KeyBanc raised its price target for Alphabet to $360, citing favorable artificial intelligence market conditions, while Stifel lifted its target to $346, pointing to healthy advertising trends in Search and YouTube. DA Davidson called out Microsoft’s Azure cloud as growing faster than peers and observed that Microsoft’s shares currently trade below the company’s historical valuation range, according to the analyst note. Separately, OpenAI’s CEO Sam Altman announced plans to roll out several Codex-related products with an expressed emphasis on cybersecurity.

Taken together, these updates reflect a series of strategic, legal, and analyst-driven developments across the technology sector that accompany Aletheia’s initiation on Teradyne.

Risks

  • Forecast uncertainty: Aletheia’s earnings projection depends on the pace and scale of chiplet adoption and new device wins, both of which may deviate from expectations - this impacts the semiconductor equipment and broader technology sectors.
  • Customer and content risk: The degree to which Teradyne secures the cited device opportunities and realizes higher per-device content value will determine revenue outcomes - affecting test equipment suppliers and semiconductor OEMs.
  • Market-size projection risk: The firm’s view that the testing market could double by decade-end is an estimate that may not materialize, presenting execution and valuation risks for investors in semiconductor capital equipment.

More from Analyst Ratings

Palantir Gains After Lofty 2026 Guidance; Analysts Split on Outlook Feb 2, 2026 Freedom Capital Markets Starts Coverage of Nebius Group With Buy Rating, $108 Target Feb 2, 2026 Clear Street Starts Coverage on Caribou Biosciences with Buy Rating and $13 Target Feb 2, 2026 Goldman Keeps OLN Neutral at $22 as Olin Signals Rough Q1, Cost Cuts to Cushion Results Feb 2, 2026 Needham Lifts Napco Security Price Target to $49 After Robust Q2 Results Feb 2, 2026